
WellSky Biotherapies Clinic is a comprehensive software solution designed to manage all aspects of hematopoietic cell transplants (HCT), including traditional blood and marrow transplants (BMT) and novel cell therapies like CAR-T. It centralizes patient, donor, and infusion data into a single system, enhancing efficiency, compliance, and adaptability for emerging therapies.
Vendor
WellSky
Company Website
WellSky Biotherapies Clinic streamlines the transplant process by providing end-to-end management of patient data from referral through pre-transplant work-up, infusion, and post-infusion follow-up. The platform facilitates comprehensive donor selection by enabling the collection and analysis of key information for all potential donors, thereby accelerating eligibility assessments and selection processes. Users can efficiently navigate between various patient events, including HCTs, donor lymphocyte infusions (DLI), donor cell infusions (DCI), boosts, and novel cell therapies such as CAR-T. The software also supports clinical trials by allowing real-time data management and analysis across all phases, enhancing safety assessments and efficacy evaluations. Integration with the Center for International Blood and Marrow Transplant Research (CIBMTR) via AGNIS enables one-click submission of patient outcomes, with auto-population of forms to streamline workflows and reduce errors. Advanced analytics and reporting tools, including pre-defined reports and custom report writers, facilitate comprehensive data analysis and compliance with standards set by organizations such as the Foundation for the Accreditation of Cellular Therapy (FACT) and CIBMTR.
Features:
- Patient Management: Centralizes patient data across all transplant phases, providing instant access to critical information to drive research and improve outcomes.
- Donor Selection: Enhances and accelerates donor eligibility, work-up, ranking, and selection processes through comprehensive data collection and analysis.
- Event Management: Allows seamless navigation between various patient events, including HCTs, DLI/DCI, boosts, and novel cell therapies like CAR-T.
- Clinical Trials Management: Facilitates real-time data management and analysis across all trial phases, supporting safety and efficacy assessments.
- CIBMTR Integration: Enables one-click submission of patient outcomes via AGNIS, with auto-populated forms to streamline workflows and ensure compliance.
- Analytics and Reporting: Provides pre-defined reports and custom report writing capabilities, supporting advanced statistical analyses such as Kaplan-Meier and ANOVA.
- Compliance Management: Automates data validations and reporting to ensure adherence to standards set by FACT and CIBMTR.